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Abstract
Background: Asthma management in Australia is suboptimal. The “Guidelines for provision of a Pharmacist Only
medicine: short acting beta agonists” (SABA guidelines) and a novel West Australian “Asthma Action Plan card”
(AAP card) were concurrently developed to improve asthma management. The aim of this qualitative research was
to evaluate the collaborative, multidisciplinary and multifaceted implementation of these asthma resources and
identify the lessons learnt to inform future initiatives.
Methods: Feedback was sought about the implementation of the SABA guidelines and the AAP card using focus
groups with key stakeholders including pharmacists (×2), pharmacy assistants, asthma educators, general practitioners,
practice nurses and people with asthma (patients). Audio recordings were transcribed verbatim. Data were analysed
thematically using constant comparison. The common themes identified from the focus groups were categorised
according to a taxonomy of barriers including barriers related to knowledge, attitudes and behaviour.
Results: Seven focus group sessions were held with 57 participants. Knowledge barriers were identified included a lack
of awareness and lack of familiarity of the resources. There was a significant lack of awareness of the AAP card where
passive implementation methods had been utilised. Pharmacists had good awareness of the SABA guidelines but
pharmacy assistants were unaware of the guidelines despite significant involvement in the sale of SABAs.
Environmental barriers included time and workflow issues and the role of the pharmacy assistant in the organisation
workflows of the pharmacy. The attitudes and behaviours of health professionals and patients with asthma were
discordant and this undermined optimal asthma management. Suggestions to improve asthma management included
the use of legislation, the use of electronic resources integrated into workflows and training pharmacists or practice
nurses to provide patients with written asthma action plans.
Conclusions: Greater consideration needs to be given to implementation of resources to improve awareness and
overcome barriers to utilisation. Attitudes and behaviours of both health professionals and patients with asthma need
to be addressed. Interventions directed toward health professionals should focus on skills needs related to achieving
improved communication and patient behaviour change.
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Background
Asthma remains a significant health problem in
Australia and is associated with significant morbidity,
mortality and decreased quality of life [1, 2]. Patients
with asthma are required to make day-to-day decisions
about how to manage their health. Effective self-
management requires the collaboration of all the mem-
bers of the primary health care team, including general
practitioners, community pharmacists, asthma educators
and practice nurses, in collaboration with the patient.
Effective self-management should also involve the use of a
written asthma action plan and appropriate use of
“preventer” and “reliever” medications [1]. Written asthma
action plans have been proven to reduce mortality,
hospitalisations and urgent GP visits [1]. Regular use of
“preventer” medications, in appropriate patients, controls
the disease and prevents exacerbations [3]. The drug class
that is primarily used for this purpose is inhaled cortico-
steroids. Asthma “reliever” medications are short-acting
bronchodilator medicines that provide rapid symptom
relief. However it is also acknowledged that regular or
excessive reliance on these medications can contribute to
poor asthma control and can put the patient at risk of a
severe, possibly life-threatening, exacerbation of the
disease [1, 4].
Despite the availability of effective evidence-based man-
agement strategies, asthma management in Australia
remains suboptimal. Ownership of written asthma action
plans remains low, at under 25 % nationally, even though
they have been recommended in national guidelines for
more than 20 years [1, 3, 4]. Analysis of dispensing data
indicates that most inhaled corticosteroids are neither pre-
scribed nor used according to current asthma guidelines
and there is an over-reliance on “reliever” medications [1].
In Australia, community pharmacists are the most fre-
quently accessed primary health care provider [5]. They
also play a key role by supplying the medications used to
treat asthma. This responsibility is even more critical
due to legislation that allows patients to access “reliever”
medications without a prescription from their general
practitioner (Schedule 3–“Pharmacist Only Medication”)
[6]. The sale of reliever medications must be under the
direct supervision of a pharmacist, which means, phar-
macists may often be the only health care professional in
a position to regularly assess the patient with asthma.
Despite the importance of this role, previous research
demonstrated patient assessment, in non-prescription
asthma reliever purchases in community pharmacy in
Western Australia, to be inadequate [7]. Subsequently
the “Guidelines for provision of a Pharmacist Only medi-
cine: short acting beta agonists” (SABA guidelines) (Fig 1)
were developed to outline best practice for pharmacists.
In 2011 the Pharmaceutical Society of Australia (PSA)
adopted the SABA guidelines nationally [8]. Concurrently
the Health Department of Western Australia’s Respiratory
Health Network developed another novel multidisciplinary
resource, the Asthma Action Plan (AAP) card (Figs. 2a, b).
The AAP card is a portable credit card sized tool that
contains a written asthma action plan and includes a
section to record medication purchases. It was designed to
complement the guidelines, streamline the referral process,
encourage patient self-management, improve collaboration
and communication and increase the ownership of written
asthma action plans [9, 10].
The implementation of the SABA guidelines and The
AAP card, was undertaken by the University of Western
Australia (UWA), the Respiratory Health Network of the
Health Department of Western Australia (HDWA), the
Asthma Foundation of Western Australia (AFWA) and
the Pharmaceutical Society of Western Australia (PSWA)
[10]. The intervention was unique because of its collab-
orative, multifaceted and multidisciplinary approach. The
multifaceted implementation involved targeting pharma-
cists, patients and general practitioners and used strategies
including lectures, educational outreach (academic detail-
ing), educational information packs and media releases via
professional networks [10]. The 4-month implementation
resulted in the distribution of more than 47,000 AAP
cards and provision of academic detailing and/or informa-
tion packs to more than 500 pharmacies (including all
pharmacies in the Perth metropolitan area) [10].
The aim of this research was to evaluate the implemen-
tation of the “Guidelines for provision of a Pharmacist
Only medicine: short acting beta agonists (SABA guide-
lines)” and “Asthma Action Plan (AAP) card”. The specific
objective was to understand the successes and failures of
this initiative in influencing health professional practice




Ethics approval was obtained from the UWA Human
Research and Ethics Committee (HREC RA/4/1/5000).
In accordance with the approval requirements written
informed consent was obtained from all participants in
this research.
PICOT framework for initial implementation
Table 1 outlines the details of the initial implementation
of the asthma resources using the PICOT framework.
Evaluation methods
A qualitative approach underpinned epistemologically by
pragmatism and utilising focus groups, was used for this
research [11, 12]. The advantage of a qualitative ap-
proach is that it provides an understanding of the per-
spective of stakeholders and the barriers that exist to
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Fig. 1 SABA guidelines in PDF format
Fig. 2 a Asthma action plan card (front) in JPEG format. b Asthma Action Plan Card (back) in JPEG format
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practice change [13]. Implementation research has dem-
onstrated that identification of barriers and tailoring
implementation strategies to overcome barriers, may
lead to improved patient care [14].
Seven focus group sessions were held with key stake-
holders in asthma management in the primary care setting
and those targeted in the SABA guideline and AAP card im-
plementation. Including a range of stakeholder groups from
care pathways facilitated a greater understanding of the bar-
riers resulting from a lack of collaboration and barriers asso-
ciated with perceptions of individuals about their role. As
such, focus groups were conducted separately with pharma-
cists (×2), pharmacy assistants, asthma educators, general
practitioners, practice nurses and people with asthma
(patients). Having groups of participants with similarities
allowed for exploration of shared experiences to gain an un-
derstanding of the issues around asthma management. This
approach is consistent with the views of Krueger and Casey
who noted there was a decrease in the quality of data from
groups composed of highly diverse participants [15].
Participant recruitment
Purposeful sampling was used to recruit focus group partic-
ipants [16]. Initial recruitment was via professional organi-
sations and patient networks. Additional methods included
the use of letters and direct emailing of individual pharma-
cies, medical practices and contacts from the primary au-
thor’s professional network. Strategies were triangulated
where necessary to ensure adequate recruitment numbers.
The aim was to recruit between four and 12 participants as
is consistent with optimal idea exchange within focus
groups [15, 17, 18]. Written informed consent was obtained
for participation and for audio recording. Participants from
all groups received a retail gift voucher of nominal value to
compensate for their time and travel costs, except for the
asthma educators who attended the session as part of their
normal working hours.
Focus group format
The quality of data generated from focus groups depends
on the skill and impartiality of the facilitator [11, 15]. An
experienced focus group facilitator, who was not a stake-
holder, was recruited from the School of Population
Health at the University of Western Australia to facilitate
discussions. She was subsequently invited to collaborate
with the research team as a co-author. A researcher (KW)
and the facilitator (CF) attended each focus group session.
The researcher did not participate in discussions but took
detailed field notes of the session. Krueger noted that it
was important for the person responsible for analysis to
be present in focus groups due to the subtleties of mood,
energy and enthusiasm that convey rich information
that cannot be determined via transcripts alone [15].
“Immersion” in the data provided a deeper under-
standing and enhanced interpretation [13, 15]. En-
gaging the same facilitator allowed for minimal
variation in delivery style between focus groups. The
facilitator was provided with a structured format to
ensure uniformity in the way focus groups were con-
ducted. This included: An introduction, explanation
of the ground rules (e.g. manners, confidentiality), ex-
planation of procedural issues (e.g. audio recording)
and information about participation and consent. This
structured approach provided reassurance to partici-
pants that they were in a safe and non-threatening
environment [16]. The focus groups were timed to
last for approximately 1 hour. The priority in holding
focus groups was to get a broad perspective from a
variety of stakeholders. While there was stakeholder
heterogeneity between groups repetition of common
themes was evident providing confidence that satur-
ation of the main themes was achieved [12, 15].
As the SABA guidelines are clinical guidelines specific-
ally for pharmacists, only pharmacy staff (pharmacists &
assistants) discussed the guidelines in focus group ses-
sions. The AAP card is a multidisciplinary resource and
as such was discussed in all of the focus group sessions.
Where participants were unaware of the card they were
given a sample of the resource along with a brief explan-
ation of its purpose and asked to speak hypothetically
about their impressions of the tool.
Topics for discussion included participants’ knowledge
of the guidelines and card, opinions about usefulness
and usability of the resources, barriers inhibiting their
use and ideas to improve the resource and/or asthma
management (Additional file 1).
Data collection
Data were collected in three ways from the focus group
sessions:
1. Researcher observations and field notes
Table 1 PICOT framework for initial implementation [10]
PICOT Prompts
Population Stakeholders in asthma management in the primary care
setting including:
Pharmacists, pharmacy assistants, asthma educators,
general practitioners, practice nurses and people with
asthma.
Intervention Collaborative, multifaceted and multidisciplinary
implementation of AAP card and national endorsement
and implementation of the SABA guidelines including a
comprehensive educational outreach programme.
Comparison Usual practice.
Outcomes Increased ownership and use of written asthma action
plans by patients and SABA guideline based practice by
pharmacists.
Timing Intervention carried out over a 4-month period between
November 2010 and February 2011
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2. Audio recordings
3. Participant demographics and written summary of
key opinions.
Field notes, which have been argued to play an important
role in accurately representing discussions [11] included
detailed participant responses, descriptive information and
numerical data about resource awareness, as has been de-
scribed by Krueger and Casey [15]. The field notes were
utilised in the analysis in conjunction with the transcripts
and provided context and emotion not always conveyed by
the written quotes alone.
Participants were asked at the end of the focus
group discussion to independently fill out a summary
sheet of perspectives. Summarising critical points in
this way was a method of confirming the accuracy of
findings (Additional file 2).
Data analysis
Having the primary researcher (KW) present at all focus
group sessions provided opportunities for the analytical
process to begin during data collection [15, 19]. Audio
recordings were transcribed verbatim. To ensure meth-
odological rigour, transcripts were thematically analysed
independently by two researchers (KW, JM) [11, 15].
Inter-coder agreement was checked and a moderator
was available (CS) where necessary to achieve consensus
[12, 13]. The analysis included inductive category devel-
opment to allow the categories to be informed by the
data rather than using a pre-conceived framework ap-
proach [13, 16]. The process of analysis involved:
Step 1: Immersion in the data through reading and
re-reading transcripts
Step 2: Highlighting words or phrases that capture key
thoughts and making notes of first impressions on
analysis
Step 3: Labelling similar thoughts with a code
(development of coding scheme)
Step 4: Codes grouped into broader categories based on
similarities
Step 5: Themes identified based on a greater
understanding of the relationships between categories
and the identification of patterns in the data.
The technique used was consistent with constant com-
parison [11, 15, 19]. This process was reflective and
iterative and involved continual refinement and revision
of codes and broader categories over the course of the
analytical process. It also involved concurrent develop-
ment of an understanding of the relationships between
codes and categories through not only the use of tran-
scripts but also field notes. This conceptual understand-
ing led to the identification of themes from the data.
Thematic analysis involved comparison of similarities
and differences across stakeholder groups [15]. It also
provided clarity about the barriers and facilitators to the
use of the resources and asthma management in general.
An inductive approach was taken with the thematic
analysis and subsequent application of the knowledge,
attitudes and behaviour theoretical framework and tax-
onomy allowed for interpretation of what influences
guideline-based practice [20, 21]. Briefly, the taxonomy
comprises 7 general categories relating to knowledge (lack
of awareness or lack of familiarity), attitudes (lack of agree-
ment, lack of self-efficacy, lack of outcome expectancy, or
the inertia of previous practice), and behavior (external
barriers) [20]. Use of a taxonomy allows for greater
applicability of the results of this research.
Summary sheet data was analysed in conjunction with
the focus group transcripts.
Results
Focus group participation and demographics
A total of seven focus group sessions were held with 57
participants. Nine and ten participants attended the two
pharmacist focus groups respectively. Other groups in-
cluded: pharmacy assistants (11 participants), practice
nurses (six participants), asthma educators (five partici-
pants), general practitioners (six participants) and pa-
tients (ten participants). The patient group had an even
gender spread (four male and six female) and an age
range of 21 to 80 years with a mean age of 51.8 years.
The participant demographics are shown in Table 2.
Benefits of resources
Community pharmacists displayed a positive attitude to-
wards the SABA guidelines. In this study they articulated
clear benefits in having formal clinical guidelines for the
non-prescription supply of short acting beta agonists.
They saw the guidelines as a useful education, clinical and
communication resource that enhanced professionalism.
I have been using them [the guidelines] as a teaching
technique for new staff, students, more as a training
guide than anything. (PHARMACIST)
It’s a good starting point and you might just tease out
something from them [patients] by working through
the guidelines…[something] they hadn’t been doing
right. (PHARMACIST)
It’s a way of getting information from patients and
finding if things are working as they’re supposed to be.
(PHARMACIST)
If we’re trying to project an image of being professional
rather than competing with supermarkets then it is a
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good idea for all pharmacies to adopt.
(PHARMACIST)
There was also recognition that having formal guide-
lines for non-prescription supply of SABAs improved
medication accessibility for patients.
Without these sort of guidelines it is not likely a lot of
these medicines would be available over the counter…
It’s probably reducing the workload on doctors as well.
(PHARMACIST)
While all participants in the groups could hypothetic-
ally acknowledge the potential benefits of the AAP card,
the focus and enthusiasm for discussion related to nega-
tive aspects of the AAP card. Many of the barriers men-
tioned challenged the realisation of the hypothetical
benefits in practical application. Furthermore barriers
often related to development and use of written asthma
action plans and asthma management in general rather
than specifically the AAP card.
Barriers to resource use
The barriers identified to the use of the SABA guidelines
and AAP card are shown in Fig. 3. The barriers were
classified according to an existing taxonomy [20].
Knowledge barriers
Lack of awareness
There was high awareness of the SABA guidelines
among pharmacists (group 1 89 %, group 2 100 %) and
similarly a high awareness of the AAP card (group 1
89 %, group 2 100 %). In contrast the participants in the
pharmacy assistant group were completely unaware of
the SABA guidelines (0 %) but had a good awareness of
the AAP card (91 %). The only other group with partici-
pants who had much familiarity of the asthma resources
was the asthma educator focus group. All of the asthma
educator participants (100 %) were aware of both the
SABA guidelines and the AAP card. Participants in the
general practitioner and practice nurse group were com-
pletely unaware of the SABA guidelines and had minimal
awareness of the AAP card (33 and 17 % respectively).
Only 20 % of patient group participants were aware of the
AAP card, despite the card being marketed as a patient
resource.


















9 (3:6) 10 (0:10) 11 (1:10) 6 (0:6) 5 (0:5) 6 (2:4) 10 (4:6)
Age (Average) (Range) 41.5 (26–57) 31 (23–60) 27.6 (19–49) 61.7 (50–72) 42.6 (23–60) 49 (41–57) 51.8 (21–80)
Hours of work
(Full time)
3 9 6 0 5 3 N/A
Awareness of Asthma
Action Plan card
8 (89 %) 10 (100 %) 10 (91 %) 2 (33 %) 5 (100 %) 1 (17 %) 2 (20 %)
Use of Asthma Action
Plan card (current
or previous)
5 (56 %) 5 (50 %) 5 (45 %) 0 (0 %) 2 (40 %) 0 (0 %) 0 (0 %)
Awareness of SABA
guidelines
8 (89 %) 10 (100 %) 0 (0 %) 0 (0 %) 5 (100 %) 0 (0 %) N/A
Fig. 3 Barriers to use of asthma resources
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Lack of familiarity
Although the majority of pharmacists, pharmacy assistants
and asthma educators were aware of the AAP card only
49 % had previously used the cards in practice and no par-
ticipants had continued to use them. No patient reported
using the AAP card to assist in self-management of his or
her asthma. This lack of experience with use of the AAP
card meant that in many instances the focus group partici-
pants were speaking about initial impressions of the tool
and its hypothetical use. As a consequence our focus
changed and the discussion broadened towards a more
general conversation about issues in asthma management
and written asthma action plans.
Attitudinal barriers
Lack of self-efficacy–the need to prioritise work
Pharmacists mentioned that with the time constraints
they often faced in daily practice that they had to priori-
tise their work. They felt that they couldn’t do all the
tasks for ideal patient management.
Sometimes in the pharmacy there’s usually only a
single pharmacist on duty…and you have to run….
that’s part of working, isn’t it, sometimes you just keep
on doing what’s most important, and it’s time.
(PHARMACIST)
Lack of self-efficacy–inability to engage patients
While patient behaviors were considered to be obstruct-
ive to guidelines-based care there was also evidence that
the attitude of pharmacists was that there was little they
could do to alter the situation. There was a feeling that
they were disempowered to practice according to the
SABA guidelines.
The main problem with the guidelines is that the
people who need the discussion to happen the most are
the ones who are least likely to talk to you in a lot of
instances. (PHARMACIST)
So they [the patients] seem to think it is their
god-given right to be handed their Ventolin® and just
resent being asked questions. (PHARMACIST)
Lack of outcome expectancy
When it came to the discussion about the AAP card the
views of pharmacists and pharmacy assistants were particu-
larly important, as they were essentially the only group that
included participants that had attempted to use the resource.
Pharmacists felt unsupported in their attempts to use
the card. This included lack of stakeholder support from
patients, general practitioners and even the health sys-
tem (in terms of legislative support to encourage better
self-management by patients with asthma). All pharma-
cists indicated they had “given” up using the card.
If [the patients] are not interested …I [the pharmacist]
am not. (PHARMACIST)
I still give [the card] out, and everyone in my shop still
gives it out, but we never see, we rarely see anyone
bringing it in a second time. (PHARMACY ASSISTANT)
Pharmacy assistants had a negative view of patients
with asthma and little understanding of the reasoning
behind their behaviour and resistance to engage.
They were also more likely than pharmacists to view the
AAP card as a punitive monitoring tool than as a referral
tool or a way of improving asthma action plan ownership.
If customers are using these [cards] you know they are
genuine. You don’t have to be suspicious of them just
coming in and buying reliever medications.
(PHARMACY ASSISTANT)
Pharmacists were more likely to see the reluctance for
patients to engage in conversation as a result of lack of un-
derstanding, however, pharmacy assistants tended to focus
on negative perceived patient attributes, such as laziness.
Vagueness…people might start off with [the card] the
first time and then they can’t be bothered.
(PHARMACY ASSISTANT)
Waste of time, as people get too lazy to bring in card
(PHARMACY ASSISTANT- Summary Sheet)
While there was much malignment of patient unwilling-
ness to engage, it would seem that attitudes of pharma-
cists and pharmacy assistants in the community pharmacy
were not conducive to improving the situation. Although
these attitudes were conveyed in relation to the resources,
it was clear that they applied to engaging with asthma pa-
tients in all instances. Not just in specific circumstances.
Behavioural barriers
Patient-related barriers
There was much discussion surrounding resistance of
patients to interactions with health professionals and the
view that patients preferred to self-manage their asthma.
Patient behaviour and engagement difficulties were seen
as a significant barrier to the success of the card and also
as a barrier to optimal management of asthma. Health
professionals believed that patients with asthma did not
want their help and would “do their own thing” regard-
less of the advice they were given. Some found patients
became aggressive in response to attempts to intervene.
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There was little acknowledgement of the patient per-
spective or reflective thinking about the motivations
behind patient behaviour.
People get, even with the pharmacist, really antsy.
[They say] I’ve been using this for a while, why do
you need to ask me all these questions.
(PHARMACIST)
Since they are the customer and they are going to get
[the reliever medication] anyway they just go…yeah,
yeah, yeah, yeah, yeah [to your questions].
(PHARMACY ASSISTANT)
I did try once to get people to come back for the
asthma education plan and come the next visit, nope,
it’s really dispiriting. (PRACTICE NURSE)
Patient unwilling–capability (PRACTICE
NURSE–Summary Sheet)
I’ve never had [a card] handed over to me to fill out….
I’ve never had a client bring one in…never. [Chorus of
agreement] (ASTHMA EDUCATOR)
The majority of asthmatics I see rely purely on
Ventolin® or similar, and the reason’s because the
preventers are cortisone based and there’s enormous
prejudice against them. They won’t use them,
particularly parents. (GENERAL PRACTITIONER)
Even the patient group acknowledged that they them-
selves were often ambivalent and “part of the problem”
in achieving optimal asthma management.
I wouldn’t be bothered, couldn’t be bothered carrying
[the card] around…You’d have to be just about dying
not to be able to tell somebody to dial 000, you’ve got
asthma. (PATIENT)
It’s probably only a matter of time before I have
another severe attack. But at this stage, if it’s not
happening, you don’t think about it. (PATIENT)
I’d been wheezing all day and hadn’t paid attention to
it [my asthma]…my husband’s a GP but he was out and
by the time he came home then I passed out and he had
to resuscitate me. (PATIENT)
Environmental barriers–collaborative care difficulties
Although patient engagement was considered the
major barrier to use of written asthma action plans
(including the AAP card) and optimal asthma man-
agement, the general practitioner was also seen by
other stakeholder groups to be unsupportive of
collaborative care initiatives. There was frustration in
the fact that general practitioners had the ultimate
responsibility to provide patients a written asthma
action plan and were seen not to be fulfilling that
role.
At the end of the day [written asthma action plans]
have to be done by a GP. We can’t give this
information…we can refer…. I don’t think GPs are
being proactive enough in making sure patients
actually have one. (PHARMACIST)
Doctors just don’t seem to follow up and do it [fill in
the card with an action plan]…. Patients come back
and say their doctor didn’t want to know about it.
(PHARMACIST)
I’ll sometimes write it out [a written asthma action
plan] and the doctor will sign it…but it’s still up to
them actually…that’s the biggest problem.
(PRACTICE NURSE)
It is just not going to happen [GPs writing asthma
action plans]. I think GPs are as complacent about
asthma as the general community. (ASTHMA
EDUCATOR)
The attitudes of many health professionals showed
little understanding of the GP perspective and the
difficulties they faced in managing patients with
asthma.
General practitioners acknowledged that there were
barriers in their practice that prevented them from man-
aging patients with asthma and providing patients with
written asthma action plans. They particularly felt frus-
trated that patients would only present when unwell,
which did not allow for chronic disease management,
only the provision of acute care.
People will present when they get a flare up, get some
treatment, but they don’t come back to discuss a plan
for next time. (GENERAL PRACTITIONER)
You’re just dealing with the acute flare up and
managing that…They don’t really want to come in
afterwards and do…longer term planning when they’re
well, because they’re well and they don’t feel like
attending then, to do that, they’ve got too many other
things to do. (GENERAL PRACTITIONER)
It’s usually just; oh they need a script along with all
the other stuff. They don’t always have the time to
deal with asthma…and it’s down the bottom of their
list. (GENERAL PRACTITIONER)
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Time in general practice (GENERAL PRACTITIONER-
Summary Sheet)
Practice nurses echoed this sentiment.
You give them opportunistic education…not a formal
clinic thing, because it’s just impossible. (PRACTICE
NURSE)
We do really get more acute people…they arrive to us,
having an acute asthma attack. (PRACTICE NURSE)
The asthma two-step plan…we’re not really doing that.
(PRACTICE NURSE)
Environmental-related barriers–time and workflow
Time barriers were another issue identified by health
professionals and pharmacy assistants as hampering
their ability to use the card and effectively support opti-
mal asthma management.
Even in the quietest pharmacies you’re always battling
for time. Either you’re in a rush or they’re in a rush…
so there is a time factor. (PHARMACIST)
There’s a time factor as well. They [patients] are
going to be too hostile, and they don’t want to
stand around waiting [for us to fill in the card].
(PHARMACY ASSISTANT)
I don’t have time to sit down and really do
[education]…how you’re supposed to…then get them
back later [for a written asthma action plan].
(PRACTICE NURSE)
You’ve got to actually fit in the spirometry checks
as well…you’ve got to work out if you’ve got time…
so it just gets a bit difficult to provide longer
term management advice to patients.
(GENERAL PRACTITIONER)
Time consuming–should be more faster process so that
customer would be inclined to use (the AAP card).
(PHARMACY ASSISTANT- Summary Sheet)
Environmental-related barriers–the role of the pharmacy
assistant
Of particular interest in the pharmacy assistant focus
group discussion was the description of their role in
SABA sales. Currently the scheduling of salbutamol and
terbutaline inhaler medications (SABAs) in Western
Australia is according to the Standard for the Uniform
Scheduling of Medicines and Poisons (SUSMP) [22].
This recommends a classification for these medications
as Schedule 3 or “Pharmacist Only” medications. The
West Australian Poisons Regulations of 1965 indicate
that, “a Schedule 3 substance should only be sold by way
of direct personal sale by a pharmacist or an intern
pharmacist under the direct personal supervision of a
pharmacist” [6]. They also state that, “the pharmacist
must take all reasonable steps to ensure there is a thera-
peutic need for the product” [6]. Despite the legislative
requirements for pharmacist involvement and a univer-
sal lack of knowledge of the SABA guidelines, pharmacy
assistants indicated that they were highly involved in the
provision of SABAs. This involvement represents an
environmental barrier to optimal asthma management.
Guideline/resource-related barriers–the format of the
Asthma Action Plan card
There was a great deal of discussion surrounding the
format of the card. Most stakeholders commented that
patients had overloaded wallets and were not likely to
carry around a card that didn’t really serve a purpose
from the patient’s perspective.
I think people think it’s too bulky…they don’t want to
carry it around in their purse. (PHARMACY
ASSISTANT)
The customer is not going to carry this around purely
to record when they buy their Ventolin®. That’s really
the issue. They don’t see any value in that.
(PHARMACIST)
Bulky/cumbersome: could get tatty (ASTHMA
EDUCATOR–Summary Sheet)
There was criticism of the paper-based format when most
health records are being converted to an electronic format.
A card of this size is just another barrier and so much
of our recording and things we do is electronic. I think
it has become almost a little bit old fashioned.
(PHARMACIST)
The recording of Ventolin® is something that either has
to be electronic or it’s not going to happen.
(PHARMACIST)
I think all of us would agree that [a computer based
template] would be the format we’re likely to use, more
than a card, because we’re not filling out a card.
(ASTHMA EDUCATOR)
The paper-based format was also seen as problematic
due to its lack of durability.
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I think guys put it [the AAP card] in their back pockets…
and it just gets really tattered. (PHARMACIST)
Guideline/resource-related barriers–the content of the
Asthma Action Plan card
There was also criticism of the content of the card. Pharma-
cists particularly felt the dual purpose of a written asthma
action plan and beta-agonist record was confusing.
Do we want to highlight that they need an asthma
management plan, get them to a GP? Or do we actually
want a mechanism for recording? …We’re trying to do
two things here at cross-purposes. (PHARMACIST)
Many indicated that the language of the card was
inappropriate for patients.
I’d like to see the wording re-done so it’s more patient
friendly. (PRACTICE NURSE)
[The card] is not really culturally appropriate for
the indigenous population…well probably a
number of groups…English as a second language.
(ASTHMA EDUCATOR)
It was felt that important information such as
asthma first aid and definition of beta-agonist over-use
was missing.
[The card contains] emergency action but it is
not really first aid. It wouldn’t be useful….
(PRACTICE NURSE)
I don’t think that [the card] would get the message
across that you should only be using one (Ventolin®) a
month. (PATIENT)
There’s got to be some sort of awareness that there is a
problem if you’re using [reliever medications] “x”
amount of times per week…basically our guidelines
need to be exploded out to everyone else, so that way
everyone is aware…I’m using [my medication] five
times a week so I’d better go and talk to my doctor, or
talk to my pharmacist. (PHARMACIST)
Information such as peak flow and oxygen use was
seen as irrelevant for a generalised tool.
I mean, worsening asthma, peak flow 50 to 75 per
cent. Hardly anyone does peak flow now.
(PRACTICE NURSE)
Peak flow used to be popular 15 years ago but…. now
we never use it…It seems to have died a death. I
occasionally use peak flow but it’s not really helpful.
(GENERAL PRACTITIONER)
When I have given [the cards] out, people have gone to
the emergency part and [said] oxygen, so where do I
get that? You could read it as; will I need to have
oxygen at home? (ASTHMA EDUCATOR)
Discussions in the asthma educator and general practi-
tioner groups particularly focused on suggesting specific
and practical ideas to improve the card content, that ad-
dressed many of the issues mentioned above, which they
found unacceptable.
Inadequate detail on front page regarding when
asthma is under control (GENERAL
PRACTITIONER–Summary Sheet)
Instructions to patients need to be clearer
(PRACTICE NURSE- Summary Sheet)
These issues with format and content all constitute a
barrier to resource utilisation.
Solutions for improvements
There were a variety of solutions offered by all stake-
holders in all focus groups regarding the SABA guide-
lines, the AAP card and asthma management in general.
However, most of the discussion about improvements in
all groups veered towards three main themes: mandatory
recording of beta-agonist purchases, development of
electronic resources to improve asthma management
and using pharmacists and practice nurses to develop
written asthma action plans.
Mandating of SABA recording
Interestingly there was much interest by pharmacists in
strengthening the legislation around non-prescription
supply of beta agonists. The view of pharmacists in the
group was that mandating the recording of beta-agonists
would assist patient engagement and SABA guideline
compliance.
If it’s mandated, and every pharmacy has to do it
[recording patient details], then they [the patient]
can’t skip a pharmacy and go down the road where
nobody asks questions because it’s mandated and
they are going to get asked wherever they go. And it
forces…forces them to engage and forces them to
actually have a conversation with the pharmacist.
(PHARMACIST)
That [mandating] would be a good way of changing
expectations…It’s not that they [patients] don’t have
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time, it’s that they expect when they go into a retail
shop that they’re not going to be asked questions. That
they come in get what they want in a second and walk
out. (PHARMACIST)
I think the only way that it [the guidelines] is actually
going to produce dramatically improved outcomes is if
it’s mandated. (PHARMACIST)
People could sign a consent form [when purchasing
asthma relievers] …they could get phone calls from
education nurses and information sent out… stuff
like that. You could record [asthma relievers], if
they did that…it would actually help.
(PHARMACIST)
The fact that the AAP card included a beta-agonist re-
cording function was seen as pointless without legisla-
tion enforcing the recoding function.
It’s not mandatory so you just sort of lose momentum.
(PHARMACIST)
[Mandatory use of the card] could make my life
harder. Well more work for us to do, but at least
you know then that they have to use it and they
have to record it, because they can’t buy it
otherwise. (PHARMACY ASSISTANT)
Despite the popularity of the notion of mandatory
recording of SABA sales there were some concerns
raised about the importance of maintaining patient
accessibility to medication and the potential unaccept-
ability for patients of legislative change.
In certain places you have to have an asthma
card or have come from the doctor [to obtain a
beta-agonist] …there is a danger there, because if you
have someone who is having an asthma attack what
are you going to do? (PHARMACIST)
The backlash [from mandatory recording of
reliever medications] would be huge.
(ASTHMA EDUCATOR)
Electronic resources
The criticism of the AAP card being a paper-based re-
source was matched by enthusiasm for the development
of electronic resources to improve asthma management.
I don’t know whether there’s something electronic that
could be done these days, an App on the phone or
something… So much of our recording and things we
do is electronic. (PHARMACIST)
Electronic…something that you can scan on a
program…something that the [medication] history
comes up, how many [reliever medications]…starting it
that way. (PHARMACY ASSISTANT)
[Electronic action plans] are good because you can
see exactly what they’ve had. If you’re just writing
one [an action plan] out they [patients] tend to
lose it or never bring it back when you have the
next appointment. (PRACTICE NURSE)
I think keeping an electronic record of your
preventatives; your Ventolin® and so forth would be
valuable in this day and age. (PATIENT)
However there was also recognition that electronic
formats would not necessarily suit all demographics.
Not everybody has computer, especially older
patients.(PHARMACY ASSISTANT)
I think a lot of my patients…depends on age…80 year
olds wouldn’t use electronics. (GENERAL
PRACTITIONER)
Overall most health professionals felt disempowered to
intervene in asthma patient’s inappropriate self-management
and reliance on asthma reliever medications and felt that the
card did not offer solutions to this issue with its imperfect
paper-based recording function.
Improving written asthma action plan ownership
In terms of addressing the issue of lack of patient owner-
ship of written asthma action plans, again the card was
not seen as the solution. Asthma educators particularly
felt that currently existing written asthma action plan
templates were superior to the card.
You only have to look at [these other plans] and
you see, they look a lot more colourful and maybe
more likely to stick in people’s minds I think.
(ASTHMA EDUCATOR)
When explaining asthma action plans to clients, I find
these [other plans are] really simple…they’re all on one
page to look at whereas [with the AAP card] you’re
flipping. (ASTHMA EDUCATOR)
Pharmacists felt that they could play a role in writing
plans for patients.
What would be the consequences if we [pharmacists] did
actually set out an action plan? The doctors would get
upset but the patients would get one. (PHARMACIST)
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We could do an asthma educator course and become
the person who does the plan instead. (PHARMACIST)
However there was also discussion about the need to
up-skill pharmacists to take on the role of preparing
written asthma action plans for patients.
I think pharmacists do need up-skilling though to
provide this service. [Written asthma action plans]
(PHARMACIST)
Additionally there was some concern about the need
to address time and remuneration barriers before phar-
macists could undertake this expanded clinical role.
I think it comes back to the time and remuneration factor,
you know that if you are going to employ, or have
pharmacists, and have the time to do that [write asthma
plans]. There needs to be balance. I think it is a great thing
to do and a great service but we need to be able to get the
pharmacist out of the dispensary and to do that you
obviously need to be getting paid for it. (PHARMACIST)
Similarly some general practitioners felt that a solution
to improve written asthma plan ownership could be util-
isation of practice nurses to undertake the task.
Where I would probably end up using that [AAP card]
within the context of my practice would be if they
came to see the nurse to actually get the action plan
done, because that’s when we put aside a bit of time
for them to sit with the nurse and have discussions.
(GENERAL PRACTITIONER)
Do it all themselves, let [practice nurses] get on with
[writing asthma action plan]. (GENERAL
PRACTITIONER)
However some were cautious about this proposition
and questioned the capability of practice nurses to
undertake the role.
“I’m not sure [about nurses writing asthma action plan]…
we have practice nurses but I don’t know that asthma is
their strongest area, I think they’d be happy showing
people how to use their inhalers but I’m not sure about
going through it all.” (GENERAL PRACTITIONER)
Discussion
This research explored the views of stakeholders of
asthma resources produced and implemented to im-
prove asthma management. Utilising focus groups
allowed for an in-depth understanding of the barriers
that undermine successful implementation of resources
to achieve practice change and improved patient health
outcomes. While this research focussed on specific re-
sources, the information gleaned from these focus
groups provides insight into key issues of asthma man-
agement and effective use of resources to improve
health-professional practice and patient engagement.
The lack of awareness and use of the asthma resources
was initially surprising given the comprehensive, multifa-
ceted implementation plan used by the collaborative team
which included personnel and resources from a university
research team, the government Health Department, a pro-
fessional pharmacy organisation and an asthma organisa-
tion [10]. However it is not unexpected given the evidence
in the scientific literature on clinical guideline implemen-
tation [23–26]. Despite the seemingly thorough approach
essentially all of the implementation activities involved
educational interventions using passive dissemination, to
most professionals, and educational outreach to pharma-
cists. The difference in awareness of the asthma resources
found between groups may be due to the differing dissem-
ination strategies employed. Educational interventions
have been demonstrated to be minimally effective,
particularly if they simply involve passive dissemination
[23–26]. Educational outreach has been found to be
effective in medical settings [25], however, in the com-
munity pharmacy setting, Watson and colleagues de-
monstrated no evidence of practice change using this
intervention method [27]. Clearly the first step to success-
ful implementation of guidelines and other resources is to
ensure that there is not only widespread knowledge of the
resource but also a willingness to incorporate it into prac-
tice. More consideration needs to be given to the imple-
mentation strategies employed to achieve this and there
should be less reliance on passive implementation.
Sustained practice change will not result if too many
barriers are encountered during initial attempts of prac-
titioners to use a resource. In the case of the SABA
guidelines and the AAP card the barriers encountered
were many and not just related to the resources them-
selves. It was evident that attitudes of all stakeholders
were influencing behaviours that were detrimental to op-
timal asthma management. There was a misalignment of
asthma management goals and behavioural expectations
between patients and health professionals and this dis-
cordance seemed to be central to the issue.
Overwhelmingly the perceived difficulties with patient
engagement resulted in pharmacists and pharmacy
assistants having a pessimistic view of their ability to
influence patients to appropriately self-manage their
condition. Asthma educators, general practitioners and
practice nurses were equally pessimistic and felt they
had limited opportunities to provide chronic disease
management and patient education. Apathy to engage
was even acknowledged by patients themselves. In many
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instances patients were unaware of poor asthma control
or were resigned to having asthma exacerbations and
limitations put on their lives by this chronic condition.
Patients only focussed on current symptoms and did not
have expectations of interventions by health profes-
sionals aimed at chronic disease management. These pa-
tient attitudes are consistent with much of the literature
in asthma [28, 29]. What is also known from the litera-
ture is that illness perceptions determine the way in
which asthma patients cope and self-manage this condi-
tion [30]. The focus group results convey that effective
self-management, with the support of health profes-
sionals, cannot be achieved without addressing patient
attitudes, beliefs and perceptions about asthma. The
extent of the issue warrants a community level interven-
tion directed at the patient. Resources such as the AAP
card are unlikely to have an impact without patient
acceptance and more widespread consultation should be
undertaken in resource development.
Equally health practitioner attitudes require address-
ing. There was little evidence of a patient-centred focus
by health professionals or reflection on changes that
could be made to allow for more effective patient en-
gagement. Negative perceptions had reduced the motiv-
ation of health professionals. In this study there were
indications of lack of self-efficacy and poor impressions
of outcome expectancy hampering patient engagement.
Motivation to change practice needs consideration in
any implementation of guidelines and/or resources. Re-
muneration opportunities may change prioritisation of
activities but ultimately improving outcome expectancy
is critical. In order to do this, health professionals require
not only motivation but also the skills to achieve out-
comes. Capability must be addressed. As health profes-
sionals saw patient engagement and patient attitudes as a
barrier, any asthma management intervention should
tackle their skills needs in this area and not just clinical
education needs. Health professionals require advanced
communication skills and experience with techniques such
as motivational interviewing in order to effectively adjust
practice and explore and guide patient perceptions [31].
Environmental barriers were also a key concern. It was
not surprising that many of the health practitioners
mentioned time and remuneration as barriers to practice
[21, 32]. This has been well documented. However the
most interesting finding related to how organisational
factors, in particular the role of the pharmacy assistants,
impacted on practice. What became evident, from the
focus groups, was that pharmacy-assistant involvement
was a barrier to the provision of guideline-based care in
the community pharmacy setting. Pharmacy assistants
had no knowledge of the SABA guidelines but articu-
lated being highly involved in the provision of non-
prescription asthma reliever medications and in some
cases saw it as “their responsibility”. This is consistent
with prior research in this region that observed in 47 %
of non-prescription sales of beta-agonists there was no
obvious involvement of a pharmacist [7]. The participa-
tion of pharmacy assistants is despite the current legisla-
tive requirements for direct pharmacist involvement and
despite the fact they are not qualified or trained to
undertake this role. Surprisingly, even though current le-
gislative requirements are not being met, both pharma-
cists and pharmacy assistants wanted the legislative
requirements strengthened to include mandatory re-
cording of non-prescription beta-agonist purchases.
While this may seem pointless, given current lack of
adherence to legislative requirements, mandatory recording
may have an impact because it may change the workflows
around the supply of SABAs. Current workflows in com-
munity pharmacy dictate that pharmacy assistants lacking
formal training are often the first and only point of contact
for asthma patients who are often resistant to engagement.
Mandatory recording may facilitate improvement in
asthma management because it may increase the involve-
ment of pharmacists by moving the interaction into the
dispensary for recording purposes. This would be desirable
because increased pharmacist involvement has previously
been found to result in more appropriate medical referral
of asthma patients [33]. Mandatory recording would also
provide easier opportunities for auditing legislative compli-
ance by pharmacists. Currently the Schedule 3 legislative
requirements are not routinely policed and statutory bodies
rarely prosecute breaches [34].
Discussions in focus groups about the AAP card evolved
into discussions about written asthma action plans in gen-
eral. While the AAP card had merit in the hypothetical it
was a flawed resource that was not going to be accepted
and utilised by stakeholders. The stakeholders noted there
were other preferable resources but these resources were
also underutilised and not serving the purpose of improv-
ing asthma management [1–4].
The sole authority of general practitioners to provide
written asthma action plans was seen as a barrier to pa-
tient ownership of written asthma action plans. General
practitioners lamented the lack of opportunity to man-
age asthma as a chronic illness. Practice nurses talked
about the remuneration pathways for writing asthma ac-
tion plans. In Australia, a general practitioner is eligible
to receive a Service Incentive Payment (SIP) for each
Asthma Cycle of Care completed [35]. However a mini-
mum of two asthma related consultations must be com-
pleted within 12 months and at least one of the
consultations needs to be a review consultation planned
at a previous consult [35]. Both the general practitioners
and practice nurses noted that this 2-step process was
difficult to achieve with patients not returning for their
review consultations. The observations of this barrier are
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interesting given that the Asthma Cycle of Care in
Australia has previously been modified from a 3-step
process (the Asthma 3+ Visit Plan) in response to feed-
back from respiratory physicians, general practitioners
and patients. It would seem that the simplified 2-step
Asthma Cycle of Care has not achieved its aims of en-
suring patients with asthma are provided on-going mon-
itoring. Non-attendance at asthma disease management
consultations is not an issue unique to Australia. Audit
data from the UK on avoidable deaths in asthma indi-
cated that 22 % of patients who died had missed routine
asthma appointments in the year before death [36].
Suggestions to address the inability of general practi-
tioners to ensure all patients with asthma have a written
asthma action plan included practice nurses writing
plans and pharmacists being trained to write asthma ac-
tion plans. Practice nurses may have fewer time barriers
than general practitioners but the fact that patients are
is still required to present at a general practice surgery
does not address the issue of opportunity. Community
pharmacists, alternatively, are highly accessible and as
medication experts could possibly undertake this role
with some up-skilling. This may be an avenue worth ex-
ploring to increase patient asthma action plan owner-
ship, given the on-going difficulties over the last 20 years
in addressing the issue. Time barriers are likely to be a
problem for pharmacists in undertaking this role, given
current time pressures articulated in focus group discus-
sions. Appropriate remuneration would allow for em-
ployment of extra staff and may increase pharmacist
motivation to engage in clinical service delivery [37].
There was much discussion about the AAP card being a
paper-based resource. What became evident is that most
stakeholders across all demographics prefer electronic re-
sources. This included patient-based resources in the for-
mat of smartphone Apps, along with written asthma action
plans and medication records compatible with the software
that general practitioners and pharmacists already use. A
review by Huckvale and colleagues in 2012 assessed the
content of apps designed to assist patient asthma self-
management [38]. Of the 103 apps assessed the conclusion
was that none provided a combination of reliable, compre-
hensive information and useful self-management functions
[38]. While there are plenty of electronic resources
available, more consideration needs to be given to the
production of unbiased, high quality, evidence–based
and simple-to-use resources that health professionals
can confidently recommend to patients to promote
self-management Organisational barriers relate to charac-
teristics of the work setting such as staff workload, man-
agement issues, financial considerations and structural
arrangements that govern workflows [39]. These barriers
need to be overcome for resource implementation to suc-
cessfully achieve its intended outcomes. It makes sense to
link resources to existing software used by health profes-
sionals rather than using extraneous paper-based re-
sources. Pharmacists, and general practitioners frequently
spoke about organisational barriers, such as time pres-
sures, as an issue to optimal practice. Resources that fit
into existing workflows (e.g. using existing software such
as dispensing software or prescribing software) are likely
to be more efficient [40].
Strengths
A key strength of this research was the triangulation of
data sources. Engagement with a range of stakeholders en-
abled multiple perspectives on the topic. The inclusion of
pharmacy assistants, who are not health professionals and
do not necessarily receive any formal training in medi-
cines and healthcare, provided rich information about
their influence on asthma management. The initial imple-
mentation strategy of the SABA guidelines involved phar-
macists only and did not acknowledge the workflows in
this setting that have pharmacy assistants on the front-line
of patient interaction. Running a pharmacy assistant focus
group proved valuable in allowing for unconstrained dis-
cussion by assistants who may have felt intimidated by a
structured interview or in a situation where pharmacists
were present [11, 18]. Member checking was undertaken
in the form of a written questionnaire.
Limitations
It is acknowledged that in qualitative research the re-
searchers bring personal values, assumptions and biases to
the study. The primary researcher in this study was KW.
As a research assistant for the initial SABA guideline
collaborative implementation, member of the Health
Department of Western Australia’s Respiratory Health
Network Executive Advisory Committee and community
pharmacist proprietor, KW had a thorough knowledge of
the background of the SABA guidelines, AAP card and
community pharmacy profession. Awareness of this poten-
tial for bias meant that every effort was made to ensure ob-
jectivity in the data collection and analysis. This included
using a “non-stakeholder” as a moderator, verbatim tran-
scripts of focus group discussions, multi-modal data collec-
tion (via field notes, transcripts and summary data) and
independent thematic analysis conducted by a second re-
searcher. Member checking did not involve verbal confir-
mations or access of medical records.
The findings of qualitative research are not generalis-
able and the ideas generated by these focus group dis-
cussions would need quantitative research to assess their
applicability [15–17]. Additionally the poor awareness of
the resources resulted in many of the discussions being
hypothetical, which was an unexpected limitation of the
research. Focus groups as a method have inherent limi-
tations and can only explore the barriers and facilitators
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that participants can articulate. There may be unrecog-
nised barriers and facilitators that were not uncovered
by the research methods utilised. While the use of
homogeneous focus groups allowed for frank and free
discussion it would be useful in future research to at-
tempt focus groups with heterogeneous groups of stake-
holders. This would allow for exploration of the issues
around lack of collaborative care in asthma, which were
evident in the results.
Conclusions
Using guidelines and resources to improve asthma man-
agement requires an effective implementation strategy
and consideration of knowledge, attitudinal and behav-
ioural barriers to practice change. The discordant views
of patients and health professionals regarding asthma
management are a significant barrier to resource imple-
mentation and optimal patient health outcomes and this
needs to be addressed. Interventions directed toward
health professionals should focus on skills needs related
to achieving improved communication and patient be-
haviour change.
Environmental barriers such as workflows need to be
understood for effective incorporation of resources into
practice.
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